As you imagine new possibilities for your professional future, don’t let past habits and outdated notions about “networking” hamper your transformation. This is the perfect time for you to adopt a new networking mindset and reimagine how to engage and build strong connections to advance your ambitions. In this dynamic and practical webinar, author, networking strategist, and coach J. Kelly Hoey provides fresh insights and actionable network-building tips to accelerate your reinvention (and calm any lingering networking anxieties).

What you will learn:

• Reimagine Networking:  Effective networking isn’t transactional schmoozing, so rethinking what networking is (and making it work for you) is critical for sustained success.
• Goals + Networking: Vague, open-ended requests for introductions or professional advice strain relationships. Learn why being hyper-specific with your goals and understanding why you’re seeking particular connections is an essential and considerate networking strategy.
• Networking Quick-Fixes: With a few simple changes, you can lift your network-building game (without adding endless coffee dates or Zoom meetings to your calendar).

About the author: Networking strategist and coach J. Kelly Hoey is the author of Build Your Dream Network: Forging Powerful Relationships In A Hyper-Connected World. Kelly’s career has evolved from law to management to entrepreneurship. Being invited to lead a global business network for women, co-founding a startup accelerator, appearing on CNBC’s Power Pitch, contributing to various publications (including New York Times, Inc., Fast Company, and Forbes), and co-creating (along with moderating) the Meet The Innovators speaker series at the Apple Store in SoHo (New York), are a few of her unanticipated career highlights. Kelly has worked with a range of organizations, including Google, Cisco, Oracle, Comcast, AMC Networks, Capital One, Canadian Digital Media Network, New Zealand Trade and Enterprise, National Australian Bank, Westpac, Prudential, PGA of America, Pfizer, Bristol-Myers, and The Tory Burch Foundation.